These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6481743)
21. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis. Sangwaiya A; Manglam V; Busbridge M; Thursz M; Arnold J Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):721-4. PubMed ID: 21654321 [TBL] [Abstract][Full Text] [Related]
22. Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica). Russo G; Guardabasso V; Romano F; Corti P; Samperi P; Condorelli A; Sainati L; Maruzzi M; Facchini E; Fasoli S; Giona F; Caselli D; Pizzato C; Marinoni M; Boscarol G; Bertoni E; Casciana ML; Tucci F; Capolsini I; Notarangelo LD; Giordano P; Ramenghi U; Colombatti R Ann Hematol; 2020 Mar; 99(3):413-420. PubMed ID: 31965272 [TBL] [Abstract][Full Text] [Related]
23. Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: a Taiwanese study. Liu TC; Lin SF; Chang CS; Yang WC; Chen TP Int J Hematol; 2004 Dec; 80(5):416-20. PubMed ID: 15646652 [TBL] [Abstract][Full Text] [Related]
24. Environmental and genetic factors in idiopathic hemochromatosis. Sinniah R Arch Intern Med; 1969 Oct; 124(4):455-60. PubMed ID: 5823015 [No Abstract] [Full Text] [Related]
25. Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. Bannerman RM; Keusch G; Kreimer-Birnbaum M; Vance VK; Vaughan S Am J Med; 1967 Mar; 42(3):476-86. PubMed ID: 6019460 [No Abstract] [Full Text] [Related]
27. Lack of adverse side effects of oral ferrous sulfate therapy in 1-year-old infants. Reeves JD; Yip R Pediatrics; 1985 Feb; 75(2):352-5. PubMed ID: 3969339 [TBL] [Abstract][Full Text] [Related]
28. The effect of iron fortification of the diet on clinical iron overload in the general population. Olsson KS; Säfwenberg J; Ritter B Ann N Y Acad Sci; 1988; 526():290-300. PubMed ID: 3164602 [TBL] [Abstract][Full Text] [Related]
29. Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat. Florence A; Ward RJ; Peters TJ; Crichton RR Biochem Pharmacol; 1992 Sep; 44(6):1023-7. PubMed ID: 1417929 [TBL] [Abstract][Full Text] [Related]
30. Iron toxicity studies of quelamycin. Brugarolas A; Perez Llanderal JA; Garcia Miralles MT; Lacave AJ; Gracia Marco M; Izquierdo JM; Rodriguez Llorian AC; Ribas A Cancer Treat Rep; 1979 May; 63(5):909-13. PubMed ID: 455332 [TBL] [Abstract][Full Text] [Related]
31. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717 [TBL] [Abstract][Full Text] [Related]
32. Clinical and chemical interactions between iron preparations and ciprofloxacin. Kara M; Hasinoff BB; McKay DW; Campbell NR Br J Clin Pharmacol; 1991 Mar; 31(3):257-61. PubMed ID: 2054264 [TBL] [Abstract][Full Text] [Related]
33. [Bioavailability of orally administered iron. Effects of alginate/antacid administration]. Campo S; Breda E Minerva Med; 1992 Mar; 83(3):145-7. PubMed ID: 1553063 [TBL] [Abstract][Full Text] [Related]
34. Esophageal injury as a result of ingestion of iron tablets. Zhang ST; Wong WM; Hu WH; Trendell-Smith NJ; Wong BC J Gastroenterol Hepatol; 2003 Apr; 18(4):466-7. PubMed ID: 12653903 [No Abstract] [Full Text] [Related]
35. High Consumption of Iron Exacerbates Hyperlipidemia, Atherosclerosis, and Female Sterility in Zebrafish via Acceleration of Glycation and Degradation of Serum Lipoproteins. Kim SH; Yadav D; Kim SJ; Kim JR; Cho KH Nutrients; 2017 Jul; 9(7):. PubMed ID: 28671593 [TBL] [Abstract][Full Text] [Related]
36. [Acute accidental oral iron poisoning of drug origin in pediatrics]. Pierron H; Sauzay F; Bellon-Serre V; Sepulcre J; Perrimond H; David JM Ann Pediatr (Paris); 1987 Apr; 34(4):333-5. PubMed ID: 3605980 [No Abstract] [Full Text] [Related]
37. Ferritin excretion and iron balance in humans. Skikne BS; Whittaker P; Cooke A; Cook JD Br J Haematol; 1995 Jul; 90(3):681-7. PubMed ID: 7647009 [TBL] [Abstract][Full Text] [Related]
38. [Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron]. Casparis D; Del Carlo P; Branconi F; Grossi A; Merante D; Gafforio L Minerva Ginecol; 1996 Nov; 48(11):511-8. PubMed ID: 9005381 [TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma in a non-cirrhotic coal miner with secondary haemochromatosis. De Tomás J; Louredo A; Turégano F; Alonso A; Martín-Merino MR Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):633-4. PubMed ID: 9222743 [TBL] [Abstract][Full Text] [Related]
40. Can iron fortification of flour cause damage to genetic susceptibles (idiopathic haemochromatosis and beta-thalassaemia major)? Bothwell TH; Derman D; Bezwoda WR; Torrance JD; Charlton RW Hum Genet Suppl; 1978; (1):131-7. PubMed ID: 285024 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]